Status:
COMPLETED
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
Lead Sponsor:
University of Aberdeen
Collaborating Sponsors:
Versus Arthritis
Conditions:
Rheumatoid Arthritis
Lupus Erythematosus, Systemic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fatigue is common and disabling for most patients with inflammatory rheumatic disease. Therapies designed to improve physical activity and 'talking' treatments, which positively help patients change t...
Detailed Description
Eligible participants will be identified from patients with inflammatory rheumatic diseases attending major secondary care rheumatology services in the United Kingdom. Potential participants will be i...
Eligibility Criteria
Inclusion
- be ≥ 18 years at the time of consent
- have been diagnosed with rheumatoid arthritis (RA), systemic lupus erythematous (SLE), axial spondyloarthritis (AxSpA) or psoriatic arthritis (PSA) by a rheumatologist
- report fatigue to be a persistent problem
- have access to a telephone landline or mobile telephone and/or internet based audio/video calls
- give permission for researchers to access their hospital medical notes
- currently be under the care of a secondary care physician
- have stable disease as evidenced by no change in immunomodulatory therapy within the last three months based on the hospital medical record
Exclusion
- there are significant abnormalities of thyroid function (TSH levels) on the most recent blood test done within the last three months
- there is evidence of severe anaemia (haemoglobin levels) on the most recent blood test done within the last three months
- there is evidence of severe renal dysfunction (eGFR) on the most recent blood test done within the last three months
- they have a medical condition which would make the proposed interventions unsuitable, e.g. significant heart disease
- they are pregnant
- they are unable to understand English sufficiently to take part in the intervention
- they are unable to provide written informed consent
- they are not willing to be randomised
- they are currently participating in an interventional clinical trial
Key Trial Info
Start Date :
September 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 2 2020
Estimated Enrollment :
368 Patients enrolled
Trial Details
Trial ID
NCT03248518
Start Date
September 5 2017
End Date
November 2 2020
Last Update
September 16 2021
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
NHS Grampian
Aberdeen, United Kingdom
2
NHS Tayside
Dundee, United Kingdom
3
NHS Lothian
Edinburgh, United Kingdom
4
NHS Greater Glasgow and Clyde
Glasgow, United Kingdom